COMMUNIQUÉS West-GlobeNewswire
-
C4 Therapeutics Outlines Strategic Milestones to Advance Cemsidomide as a Potential Best-in-Class IKZF1/3 Degrader and Discovery Strategy Focused on Novel Targets in Clinically Validated Pathways
14/01/2026 -
NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA in Support of NRX-100 Approval
14/01/2026 -
Glucose Health, Inc. Reports Debt-Free Balance Sheet and Previews New Soluble Fiber Brand
14/01/2026 -
Emergent BioSolutions Receives U.S. FDA Approval on Supplemental New Drug Application for NARCAN® Nasal Spray to be Packaged in a New Carrying Case, Making Life-Saving Naloxone More Accessible for Everyday Preparedness
14/01/2026 -
Statement from Unity Consortium on Announced Changes to the U.S. Childhood and Adolescent Immunization Schedule
14/01/2026 -
Patterson Dental and Dentsply Sirona Renew U.S. Dental Technology Distribution Partnership
14/01/2026 -
ApolloMD Announces Leadership Appointments to Strengthen Hospital Operations and Revenue Performance
14/01/2026 -
Altanine Shares Industry Perspective on the Future of Generics and the Role of Value-Added Formulations
14/01/2026 -
Plus Therapeutics Announces Pricing of Upsized $15 Million Public Offering
14/01/2026 -
NDT Pharmaceuticals, Inc.’s Wholly Owned Subsidiary, Good Salt Life, Inc., to Launch Dog Gone Odor® on Chewy and Amazon, Expanding its Rapidly Growing Biosafety Catalog
14/01/2026 -
Groundwork BioAg Expands in Brazil with Appointment of Roberto Gajardoni as Country Manager
14/01/2026 -
24/7 Market News - Kraig Labs Set to Deliver Spider Silk Fiber Samples to Three Industry Partners
14/01/2026 -
SCIENTURE Announces Issuance of Orange Book-Listable Patent Covering REZENOPY™, the Highest Dosage Naloxone HCl Nasal Spray Approved by the FDA for Life-Saving Opioid Overdose Emergency Treatment
14/01/2026 -
EMJX CEO Eric Jackson to Host Fireside Chat on EMJX Treasury OS Strategy and Governance on January 22nd
14/01/2026 -
Stead Impact Ventures Leads $15M Series A to Support MedWatch Technologies’ Mission to Advance Metabolic Wellness Innovation
14/01/2026 -
Oragenics to Present at the 2026 Sequire Investor Summit in Puerto Rico
14/01/2026 -
Beyond Air Announces $5.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
14/01/2026 -
Clover Health Announces 53% Growth in Medicare Advantage Membership During AEP, Increasing to 153,000 Members as of January 1, 2026; Expects First-Ever Full Year GAAP Net Income Profitability in 2026
14/01/2026 -
ENvue Medical Launches Over-the-Counter Reusable ENFit Syringes to Support Feeding and Medication Delivery without a Prescription
14/01/2026
Pages